CD274 and neoplasm: Few tumor-derived markers, such as the expression of PD-L1 in the tumor and tumor-infiltrating immune cells, have been acknowledged as predictive and/or prognostic factors in selected tumor types, along with microsatellite instability (MSI) status and tumor mutational burden (TMB) in more diverse tumor types [3–5].